Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for DA4S
News May 22, 2013
“It is a privilege to join the board of DA4S, and I look forward to contributing my knowledge and experience to help the organization achieve its strategic objectives,” said Bishop, whose term on the 16-member board runs through May 2017. “DA4S plays a vital role in championing the benefits of diversity within the life sciences community. I am eager to share the organization’s mission with leading life sciences companies across New England.”
“As the managing director of Caligor Rx, Tammy has demonstrated the strong, energetic and visionary leadership that supports DA4S’s mission to broaden supplier diversity across the entire life sciences community, including businesses and academic and government institutions,” said DA4S President Sylvester Wilkins. “Tammy ‘s more than 20 years of pharma industry experience and her unique entrepreneurial skills make her especially well suited to serve our board.”
Prior to joining Caligor Rx in 2010, Bishop worked in senior-level business development positions at Pharmarama and IDIS Pharmaceuticals. In addition, she served in senior corporate communications positions at OXiGENE, Gemini Genomics and Indevus Pharmaceuticals. In 2011, she was selected as a protégé for the DA4S Mentor Program and was instrumental in shepherding Caligor Rx’s national certification as a Woman-owned Business by the Women’s Business Enterprise National Council.
Bishop is a member of the Drug Information Association, Healthcare Distribution Management Association, Healthcare Women’s Business Association and Institute for Supply Chain Management. She received a Master’s Degree in Business Administration from the Simmons College School of Management.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE